NewGenIvf Group Ltd (NIVF): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$188.1K
Year ended 2025-12-31
+23.2%
3-year compound annual growth
2021-12-31: $166.7K2022-12-31: $100.5K2023-12-31: $31.2K2024-12-31: $19.5K2025-12-31: $188.1K$188.1K
2021-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$188.1K+864.6%2026-03-31, From 2025-01-01
2024-12-31$19.5K-37.4%2026-03-31, From 2024-01-01
2023-12-31$31.2K-69.0%2026-03-31, From 2023-01-01
2022-12-31$100.5K-39.7%2025-05-15, From 2022-01-01
2021-12-31$166.7Kn/a2024-08-20, From 2021-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
NewGenIvf Group Ltd (NIVF)2025-12-31$188.1K+864.6%
Cryo Cell International Inc (CCEL)2025-11-30$751.5K+55.4%
Mangoceuticals, Inc. (MGRX)2024-12-31$9.9K-60.1%
Pacific Health Care Organization Inc (PFHO)2025-12-31$24.0K-29.7%
Marpai, Inc. (MRAI)2025-12-31$381.0K-83.1%
Viemed Healthcare, Inc. (VMD)2025-12-31$28.61M+12.8%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$210.0K+11.1%
Progyny, Inc. (PGNY)2025-12-31$4.95M+55.8%
agilon health, inc. (AGL)2025-12-31$28.59M+16.9%

Compare NIVF, CCEL, MGRX, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗